We’ve long known that Scripps Research’s Dr. Brunie Felding has been studying NAD+ booster Nicotinamide Riboside “NR” (FAQs) (Anecdotes) as a possible treatment for breast cancer. But, aside from a brief mention of her work by NAD+ expert Dr. Charles Brenner, we’ve heard virtually nothing. Until now. Chromadex (sellers of NR) recently gave consumers an opportunity to ask Dr. Felding various questions via email. The following is an email response from Dr. Felding (published with permission):
Month: July 2023
Last week, Dr. Andrew Salzman joined “The Doctor’s Farmacy with Mark Hyman M.D.” to discuss NAD+, NR (FAQs), and NMN (FAQs). Dr. Salzman made the case that if you want to raise your NAD+ levels, NMN is your best option. There are 2 problems here. First, neither Dr. Salzman nor Dr. Hyman disclosed Salzman’s ties to a company that sells NMN. Second, according to Dr. Charles Brenner (FAQs), Dr. Salzman’s case for NMN’s superiority is flawed. Brenner knows this from his own work. But, first, here’s Dr. Salzman on Dr. Hyman’s podcast: